129 related articles for article (PubMed ID: 37667512)
1. Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast Cancer Outcomes Study, a population-based cohort study.
Kou K; Aitken JF; Pyke C; Chambers S; Dunn J; Baade PD
Med J Aust; 2023 Nov; 219(9):409-416. PubMed ID: 37667512
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia.
Retell JD; Cameron JK; Aitken JF; Youl P; Pyke C; Dunn J; Chambers S; Baade PD
Breast Cancer Res Treat; 2024 Feb; 203(3):575-586. PubMed ID: 37930491
[TBL] [Abstract][Full Text] [Related]
4. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.
Youl PH; Aitken JF; Turrell G; Chambers SK; Dunn J; Pyke C; Baade PD
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27869758
[TBL] [Abstract][Full Text] [Related]
6. Long-term Mortality in Individuals Diagnosed With Cancer During Pregnancy or Postpartum.
Cairncross ZF; Shack L; Nelson G; Friedenreich CM; Ray J; Fell DB; Lisonkova S; Bhatti P; Sikdar K; McMorris C; Metcalfe A
JAMA Oncol; 2023 Jun; 9(6):791-799. PubMed ID: 37022714
[TBL] [Abstract][Full Text] [Related]
7. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
8. A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia.
Baade PD; Fowler H; Kou K; Dunn J; Chambers SK; Pyke C; Aitken JF
Breast Cancer Res Treat; 2022 Sep; 195(2):191-200. PubMed ID: 35896851
[TBL] [Abstract][Full Text] [Related]
9. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
Kou K; Cameron J; Youl P; Pyke C; Chambers S; Dunn J; Aitken JF; Baade PD
Breast Cancer; 2023 May; 30(3):466-477. PubMed ID: 36809492
[TBL] [Abstract][Full Text] [Related]
10. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM
Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995
[TBL] [Abstract][Full Text] [Related]
11. Development of a key performance indicator for breast cancer in Queensland, Australia.
Walpole ET; Youl PH; Moore J; Morris M; Cossio D; Dhanda P; Theile DE; Philpot S
Breast Cancer Res Treat; 2023 Jan; 197(1):211-221. PubMed ID: 36350472
[TBL] [Abstract][Full Text] [Related]
12. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer survival, survival disparities, and guideline-based treatment.
Hill DA; Friend S; Lomo L; Wiggins C; Barry M; Prossnitz E; Royce M
Breast Cancer Res Treat; 2018 Jul; 170(2):405-414. PubMed ID: 29569018
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk among female employees of the Australian Broadcasting Corporation in Australia.
Sitas F; O'Connell DL; van Kemenade CH; Short And MW; Zhao K
Med J Aust; 2010 Jun; 192(11):651-4. PubMed ID: 20528719
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
16. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
17. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.
Arecco L; Blondeaux E; Bruzzone M; Ceppi M; Latocca MM; Marrocco C; Boutros A; Spagnolo F; Razeti MG; Favero D; Spinaci S; Condorelli M; Massarotti C; Goldrat O; Del Mastro L; Demeestere I; Lambertini M
Hum Reprod; 2022 May; 37(5):954-968. PubMed ID: 35220429
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study.
Forsyth SJ; Carroll M; Lennox N; Kinner SA
Addiction; 2018 May; 113(5):937-945. PubMed ID: 29154395
[TBL] [Abstract][Full Text] [Related]
19. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Rickett K; Feng S; Vagenas D; Woodward NE
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012988. PubMed ID: 31994181
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
